1. K-State home
  2. »Shames Lab
  3. »Publications

Shames Lab

Contact information

Division of Biology
Kansas State University
347 Ackert Hall (office)
331 Ackert Hall (lab)
1717 Claflin Road
Manhattan, KS 66506

(785) 532-0110 (office)
(785) 532-0131 (lab)

Select Publications

Gilchrist, A.K., Smolensky, D., Ngwaga, T., Chauhan, D., Cox, S., Perumal, R., Noronha, L.E., and Shames S.R. 2020. High-polyphenol extracts from Sorghum bicolor attenuate replication of Legionella pneumophila within RAW 264.7 macrophages. FEMS Microbiology Letters. In press.

Joseph, A.M., Pohl, A.E., Ball, T.J., Abram, T.G., Johnson, D.K., Geisbrecht, B.V., and Shames, S.R. 2020 The Legionella pneumophila metaeffector Lpg2505 (MesI) regulates SidI-mediated translation inhibition and novel glycosyl hydrolase activityInfection and Immunity. In press

Ngwaga, T., Hydock, A.J., Ganesan, S., and Shames, S.R. 2019. Potentiation of cytokine-mediated restriction of Legionella intracellular replication by a Dot/Icm-translocated effectorJournal of Bacteriology. 201(14):e00755-18

Shames, S.R. 2019. Screening targeted Legionella pneumophila mutant libraries in vivo using INSeq. Methods in Molecular Biology. 1921:123-144 

Shames, S.R., Liu, L., Havey, J.C., Schofield, W.B., Goodman, A.L., and Roy, C.R. 2017. Multiple Legionella pneumophila effector virulence phenotypes revealed through high-throughput analysis of targeted mutant librariesProceedings of the National Academy of Science USA. 114:E10446-E10454

Arasaki, K., Mikami, Y., Shames, S.R., Inoue, H., Wakana, Y., Tagaya, M. 2017. Legionella Effector Lpg1137 shuts down ER-mitochondria communication through cleavage of Syntaxin 17Nature Communications. 8:15406.

Tørring, T., Shames, S.R., Cho, W., Roy, C.R., Crawford, J.M. 2017. Acyl-histidines: New N-acyl amides from Legionella pneumophila. ChemBioChem. 18(7): 638-46.

Shames, S.R. and Finlay, B.B. 2012. Bacterial effector interplay: a new way to view effector function.  Trends in Microbiology.  20(5):214-219.

Shames, S.R., Croxen, M.A., Deng, W., and Finlay, B.B. 2011. The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17BInfection and Immunity.79(12): 4784-4790.

Shames, S.R., Bhavsar, A.P. Croxen, M.A., Law, R.J., Mak, S.H.C., Deng, W., Bidshari, R., de Hoog, C.L., Foster, L.J., and Finlay, B.B. 2011. The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300.  Cellular Microbiology. 13(10): 1542-1557.

Sham, H.P.†, Shames, S.R.†, Croxen, M.A., Ma, C., Chan, J., Khan, M.A., Wickham, M.E., Deng, W., Finlay, B.B., and Vallance, B.A. 2011. Attaching/effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-kB and p38-MAP Kinase activation Infection and Immunity. 79(9): 3552-3562 † - co-first authors.

Shames, S.R. and Finlay, B.B. 2011. Proteolytic Cleavage of NF-κB p65: A Novel Mechanism for Subversion of Innate Immune Signaling by Pathogenic E. coli. Frontiers in Microbiology. 2 doi: 10.3389/fmicb.2011.00038.

Shames, S.R., Deng, W., Guttman, J.A., de Hoog, C.L., Li, Y., Hardwidge, P.R., Sham, H.P., Vallance, B.A., Foster, L.J., and Finlay, B.B. 2010. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalingCellular Microbiology. 12(9): 1322-1339.

See the full list of Stephanie's publications at NCBI PubMed.


We post preprints!!